Krsnaa Diagnostics Limited

Company Profile

Krsnaa Diagnostics Limited had its IPO on under the ticker symbol KRSNAA.

The company operates in the Healthcare sector and Diagnostics & Research industry. Krsnaa Diagnostics Limited has a staff strength of 0 employees.

Stock update

Shares of Krsnaa Diagnostics Limited opened at ₹672.45 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹628 - ₹683.15, and closed at ₹638.55.

This is a -5.41% slip from the previous day's closing price.

A total volume of 21,473 shares were traded at the close of the day’s session.

In the last one week, shares of Krsnaa Diagnostics Limited have slipped by -6.72%.

Krsnaa Diagnostics Limited's Key Ratios

Krsnaa Diagnostics Limited has a market cap of ₹21.73 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Krsnaa Diagnostics Limited’s revenue was ₹5.14 billion with a gross profit of ₹4.32 billion and an EBITDA of ₹1.26 billion. The EBITDA ratio measures Krsnaa Diagnostics Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Krsnaa Diagnostics Limited’s operating margin was 13.38% while its return on assets stood at 4.8% with a return of equity of 8.73%.

In Q2, Krsnaa Diagnostics Limited’s quarterly earnings growth was a positive 0.2% while revenue growth was a positive 23.7%.

Krsnaa Diagnostics Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

35.8735

PEG

Its diluted EPS in the last 12-months stands at ₹19.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Krsnaa Diagnostics Limited’s profitability.

Krsnaa Diagnostics Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Krsnaa Diagnostics Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 12.8%.

Balance sheet and cash flow metrics

Total Assets

₹9.10 billion

Total Liabilities

₹991.94 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

12.8%

Krsnaa Diagnostics Limited ended 2024 with ₹9.10 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.10 billion while shareholder equity stood at ₹7.39 billion.

Krsnaa Diagnostics Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹991.94 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹227.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹110.00 million.

Krsnaa Diagnostics Limited’s total current assets stands at ₹2.26 billion while long-term investments were ₹0 and short-term investments were ₹978.72 million. Its net receivables were ₹730.97 million compared to accounts payable of ₹621.25 million and inventory worth ₹250.74 million.

In 2024, Krsnaa Diagnostics Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Krsnaa Diagnostics Limited paid ₹0.13 in dividends in 2024.

Other key metrics

Current Trading Price

₹638.55

52-Week High

₹699.25

52-Week Low

₹354

Analyst Target Price

₹

Krsnaa Diagnostics Limited stock is currently trading at ₹638.55 per share. It touched a 52-week high of ₹699.25 and a 52-week low of ₹699.25. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹557.68 and 200-day moving average was ₹496.09 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 4691.8% of the company’s stock are held by insiders while 3069.8% are held by institutions.